Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left">Factor </td><td align="center">Average</td><td align="center">S.E.</td><td align="center">95% C.I.</td><td align="center"><i>P</i>-value</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">Nephropathy (−)</td><td align="center">2.799</td><td align="center">0.076</td><td align="center">2.646–2.951</td><td align="center">.075</td></tr><tr><td align="left">Nephropathy (+)</td><td align="center">2.576</td><td align="center">0.095</td><td align="center">2.386–2.765</td><td align="center"></td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Comparison of ADPRCA influence on nephropathy, adjusted
for HbA1c.

Journal of Diabetes Research

tab3

Table 3

Table 3: Decreased ADP-Ribosyl Cyclase Activity in Peripheral Blood Mononuclear Cells from Diabetic Patients with Nephropathy 